Gregory Grunberg serves as Executive at Kala Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Gregory Grunberg has executed 12 insider transactions totaling $40.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 17, 2021 involved receiving (via award) 20,000 shares valued at $0.
Gregory Grunberg currently holds 40,000 shares of Kala Pharmaceuticals, Inc. (KALA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Grunberg has been a net buyer of KALA stock. They have purchased $40.4M and sold $23.5K worth of shares.
Gregory Grunberg's most recent insider trade was on Jun 17, 2021, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $27.60 |
| Discretionary |
| Nov 16, 2020 | ETNB | $0 | Other | 850 | $N/A | Discretionary |
| Nov 16, 2020 | ETNB | $0 | Other | 850,000 | $N/A | Discretionary |
| Jul 10, 2020 | ETNB | $3.0M | Purchase | 109,090 | $27.50 | Discretionary |
| Jun 25, 2020 | KALA | $0 | Award | 20,000 | $N/A | Discretionary |
| Mar 13, 2020 | KALA | $20.0M | Purchase | 2,534,854 | $7.89 | Discretionary |
| Nov 13, 2019 | ETNB | $0 | Conversion | 1,916,787 | $N/A | Discretionary |
| Nov 11, 2019 | ETNB | $9.2M | Purchase | 575,000 | $16.00 | Discretionary |
| Oct 5, 2018 | KALA | $5.0M | Purchase | 606,060 | $8.25 | Discretionary |
| Jul 25, 2017 | KALA | $3.2M | Purchase | 215,000 | $15.00 | Discretionary |
| Jul 25, 2017 | KALA | $0 | Conversion | 2,055,946 | $N/A | Discretionary |